Carl Zeiss Meditec (AFX) Ratios
Carl Zeiss Meditec Ratios
CH:AFX's free cash flow for Q3 2026 was $0.00. For the 2026 fiscal year, CH:AFX's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Sep 25 | Sep 24 | Sep 23 | Sep 22 | Sep 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.35 | 2.13 | 3.40 | 3.32 | 3.58 |
| Quick Ratio | 1.44 | 1.19 | 2.48 | 2.61 | 2.94 |
| Cash Ratio | 0.05 | 0.04 | 0.02 | 0.01 | 0.02 |
| Solvency Ratio | 0.20 | 0.23 | 0.42 | 0.46 | 0.41 |
| Operating Cash Flow Ratio | 0.39 | 0.43 | 0.45 | 0.35 | 0.81 |
| Short-Term Operating Cash Flow Coverage | 4.80 | 99.69 | 5.45 | 8.68 | 18.15 |
| Net Current Asset Value | $ -51.44M | $ -124.24M | $ 1.05B | $ 999.13M | $ 885.43M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.18 | 0.18 | 0.10 | 0.05 | 0.09 |
| Debt-to-Equity Ratio | 0.29 | 0.30 | 0.14 | 0.06 | 0.13 |
| Debt-to-Capital Ratio | 0.22 | 0.23 | 0.12 | 0.06 | 0.12 |
| Long-Term Debt-to-Capital Ratio | 0.18 | 0.18 | 0.04 | 0.04 | 0.04 |
| Financial Leverage Ratio | 1.63 | 1.66 | 1.40 | 1.40 | 1.44 |
| Debt Service Coverage Ratio | 4.20 | -28.30 | 6.24 | 12.17 | 10.77 |
| Interest Coverage Ratio | 8.39 | -12.10 | 21.45 | 44.71 | 44.14 |
| Debt to Market Cap | 0.14 | 0.07 | 0.02 | 0.01 | 0.01 |
| Interest Debt Per Share | 7.24 | 6.73 | 3.50 | 1.53 | 2.52 |
| Net Debt to EBITDA | 1.67 | 1.47 | 0.57 | 0.25 | 0.51 |
| Profitability Margins | |||||
| Gross Profit Margin | 52.76% | 52.69% | 57.71% | 59.26% | 58.73% |
| EBIT Margin | 9.90% | 13.08% | 20.48% | 21.71% | 21.16% |
| EBITDA Margin | 15.57% | 19.51% | 24.06% | 25.35% | 24.85% |
| Operating Profit Margin | 10.02% | 8.54% | 15.66% | 21.38% | 22.99% |
| Pretax Profit Margin | 8.70% | 11.66% | 19.75% | 21.20% | 20.59% |
| Net Profit Margin | 6.34% | 8.65% | 13.90% | 15.45% | 14.35% |
| Continuous Operations Profit Margin | 6.39% | 8.72% | 13.98% | 15.55% | 14.42% |
| Net Income Per EBT | 72.83% | 74.20% | 70.39% | 72.84% | 69.69% |
| EBT Per EBIT | 86.82% | 136.58% | 126.11% | 99.19% | 89.54% |
| Return on Assets (ROA) | 4.08% | 5.27% | 9.57% | 10.41% | 9.86% |
| Return on Equity (ROE) | 6.67% | 8.75% | 13.45% | 14.59% | 14.24% |
| Return on Capital Employed (ROCE) | 7.66% | 6.24% | 13.24% | 17.81% | 19.44% |
| Return on Invested Capital (ROIC) | 5.50% | 4.63% | 9.12% | 12.82% | 13.35% |
| Return on Tangible Assets | 7.73% | 10.49% | 12.32% | 13.65% | 12.35% |
| Earnings Yield | 3.83% | 2.83% | 3.92% | 3.06% | 1.59% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.22 | 3.54 | 1.61 | 1.39 | 1.27 |
| Payables Turnover | 9.66 | 5.33 | 3.68 | 4.10 | 4.67 |
| Inventory Turnover | 2.12 | 1.82 | 1.70 | 2.03 | 2.37 |
| Fixed Asset Turnover | 6.50 | 5.84 | 6.62 | 8.06 | 8.25 |
| Asset Turnover | 0.64 | 0.61 | 0.69 | 0.67 | 0.69 |
| Working Capital Turnover Ratio | 3.23 | 2.07 | 1.61 | 1.58 | 1.53 |
| Cash Conversion Cycle | 247.91 | 234.84 | 342.46 | 353.24 | 362.64 |
| Days of Sales Outstanding | 113.33 | 103.02 | 226.61 | 262.11 | 286.95 |
| Days of Inventory Outstanding | 172.36 | 200.35 | 214.91 | 180.21 | 153.81 |
| Days of Payables Outstanding | 37.78 | 68.54 | 99.06 | 89.07 | 78.13 |
| Operating Cycle | 285.69 | 303.38 | 441.53 | 442.31 | 440.76 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 2.40 | 2.78 | 2.80 | 2.10 | 4.05 |
| Free Cash Flow Per Share | 1.95 | 1.07 | 1.53 | 1.19 | 3.32 |
| Dividend Paid and CapEx Coverage Ratio | 2.28 | 0.99 | 1.18 | 1.16 | 3.27 |
| Capital Expenditure Coverage Ratio | 5.33 | 1.62 | 2.20 | 2.30 | 5.49 |
| Operating Cash Flow Coverage Ratio | 0.35 | 0.40 | 0.84 | 1.47 | 1.67 |
| Operating Cash Flow to Sales Ratio | 0.09 | 0.12 | 0.12 | 0.10 | 0.22 |
| Free Cash Flow Yield | 4.62% | 1.50% | 1.85% | 1.11% | 2.00% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 26.19 | 35.37 | 25.51 | 32.70 | 62.86 |
| Price-to-Sales (P/S) Ratio | 1.66 | 3.06 | 3.55 | 5.05 | 9.02 |
| Price-to-Book (P/B) Ratio | 1.74 | 3.10 | 3.43 | 4.77 | 8.95 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 21.65 | 66.46 | 54.07 | 90.47 | 50.08 |
| Price-to-Operating Cash Flow Ratio | 17.59 | 25.56 | 29.53 | 51.07 | 40.95 |
| Price-to-Earnings Growth (PEG) Ratio | -1.32 | -0.93 | -20.98 | 1.33 | 0.68 |
| Enterprise Value Multiple | 12.31 | 17.15 | 15.30 | 20.17 | 36.81 |
| Enterprise Value | 4.27B | 6.91B | 7.69B | 9.73B | 15.06B |
| EV to EBITDA | 12.31 | 17.15 | 15.30 | 20.17 | 36.81 |
| EV to Sales | 1.92 | 3.35 | 3.68 | 5.11 | 9.15 |
| EV to Free Cash Flow | 25.05 | 72.69 | 56.16 | 91.60 | 50.79 |
| EV to Operating Cash Flow | 20.35 | 27.96 | 30.67 | 51.70 | 41.53 |
| Tangible Book Value Per Share | 5.66 | 4.13 | 16.74 | 15.21 | 13.36 |
| Shareholders’ Equity Per Share | 24.18 | 22.98 | 24.14 | 22.53 | 18.55 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.27 | 0.25 | 0.29 | 0.27 | 0.30 |
| Revenue Per Share | 25.45 | 23.25 | 23.36 | 21.27 | 18.41 |
| Net Income Per Share | 1.61 | 2.01 | 3.25 | 3.29 | 2.64 |
| Tax Burden | 0.73 | 0.74 | 0.70 | 0.73 | 0.70 |
| Interest Burden | 0.88 | 0.89 | 0.96 | 0.98 | 0.97 |
| Research & Development to Revenue | 0.15 | 0.17 | 0.17 | 0.15 | 0.14 |
| SG&A to Revenue | 0.28 | 0.28 | 0.04 | 0.04 | 0.04 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.47 | 1.38 | 0.86 | 0.64 | 1.53 |
Currency in EUR
